A Dendritic Cell Cancer Vaccine of Matured Phenotype Downregulates Peripheral Regulatory T Cell Frequency and Identification of Plasma Protein Profiles Predicting Vaccine Efficacy - Results from a Phase II Study

被引：0
|
作者：
Wang, Who-Whong [1 ]
Chia, John [1 ]
Tan, Sze Huey [1 ]
Zocca, Mai-Britt [2 ]
Claesson, Mogens H. [3 ]
Toh, Han Chong [1 ]
机构：
[1] Natl Canc Ctr, Singapore, Singapore
[2] Dandrit Biotech A S, Copenhagen, Denmark
[3] Univ Copenhagen, Copenhagen, Denmark
来源：
MOLECULAR THERAPY | 2009年 / 17卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：S208 / S208
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma - Phase II study results
    Zahradova, L.
    Mollova, K.
    Ocadlikova, D.
    Kovarova, L.
    Adam, Z.
    Krejci, M.
    Pour, L.
    Krivanova, A.
    Sandecka, V.
    Hajek, R.
    NEOPLASMA, 2012, 59 (04) : 440 - 449
  • [2] Dendritic cell vaccine for metastatic breast cancer. Phase I/II study
    Moviglia, Gustavo A.
    Gaeta, Carlos
    Varela, Gabriela
    Farina, Fablo
    Moya, Roberto
    Paes de Lima, Andrea
    Costanzo, Herman
    Maranon, Gonzalo
    Merino, Silvia
    Guerra, O. M.
    ANNALS OF ONCOLOGY, 2004, 15 : 40 - 40
  • [3] RESULTS OF PHASE II TRIAL OF DENDRITIC CELL BASED VACCINE THERAPY IN ADVANCED EPITHELIAL OVARIAN CANCER
    Tsip, N.
    Khranovska, N.
    Vorobyova, L.
    Skachkova, O.
    Svyntsytsky, V.
    Svergun, N.
    Gorbach, O.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (08) : 85 - 85
  • [4] First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)
    Ridolfi, Laura
    Gurrieri, Lorena
    Riva, Nada
    Bulgarelli, Jenny
    De Rosa, Francesco
    Guidoboni, Massimo
    Fausti, Valentina
    Ranallo, Nicoletta
    Calpona, Sebastiano
    Tazzari, Marcella
    Petrini, Massimiliano
    Granato, Anna Maria
    Pancisi, Elena
    Foca, Flavia
    D'Allagata, Monia
    Bondi, Isabella
    Amadori, Elena
    Cortesi, Pietro
    Zani, Chiara
    Ancarani, Valentina
    Gamboni, Alessandro
    Polselli, Antonio
    Pasini, Giuseppe
    Bartolini, Daniela
    Maimone, Giuseppe
    Arpa, Donatella
    Tosatto, Luigino
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [5] Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide
    Sakakibara, Mitsuru
    Kanto, Tatsuya
    Hayakawa, Michiyo
    Kuroda, Shoko
    Miyatake, Hideki
    Itose, Ichiyo
    Miyazaki, Masanori
    Kakita, Naruyasu
    Higashitani, Koyo
    Matsubara, Tokuhiro
    Hiramatsu, Naoki
    Kasahara, Akinori
    Takehara, Tetsuo
    Hayashi, Norio
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (11) : 1565 - 1575
  • [6] Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide
    Mitsuru Sakakibara
    Tatsuya Kanto
    Michiyo Hayakawa
    Shoko Kuroda
    Hideki Miyatake
    Ichiyo Itose
    Masanori Miyazaki
    Naruyasu Kakita
    Koyo Higashitani
    Tokuhiro Matsubara
    Naoki Hiramatsu
    Akinori Kasahara
    Tetsuo Takehara
    Norio Hayashi
    Cancer Immunology, Immunotherapy, 2011, 60 : 1565 - 1575
  • [7] Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial
    Baek, Soyoung
    Kim, Choung-Soo
    Kim, Sung-Bae
    Kim, Yong-man
    Kwon, Seog-Woon
    Kim, YongMan
    Kim, HyunSoo
    Lee, Hyunah
    JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
  • [8] Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial
    Soyoung Baek
    Choung-Soo Kim
    Sung-Bae Kim
    Yong-man Kim
    Seog-Woon Kwon
    YongMan Kim
    HyunSoo Kim
    Hyunah Lee
    Journal of Translational Medicine, 9
  • [9] Results of a Phase II clinical trial with Id-protein-loaded dendritic cell vaccine in multiple myeloma: encouraging or discouraging?
    Garcia-Marquez, Maria A.
    Wennhold, Kerstin
    Draube, Andreas
    von Bergwelt-Baildon, Michael
    IMMUNOTHERAPY, 2012, 4 (10) : 991 - 994
  • [10] RESULTS FROM A FIRST IN MAN PHASE I/II ADJUVANT DENDRITIC CELL VACCINE STUDY IN HIGH RISK PROSTATE CANCER PATIENTS FOLLOWING RADICAL SURGERY
    Tryggestad, A. A.
    Bigalke, I.
    Axcrona, K.
    Inderberg, E.
    Skorstad, G.
    Honnashagen, K.
    Skoge, L.
    Tjeldhorn, L.
    Mowinckel, L.
    Saebo-Larse, S.
    Jorgensen, J. L.
    Andreassen, G. S.
    Josefsen, D.
    Axcrona, U.
    Aamdal, S.
    Lilleby, W.
    Brennhovd, B.
    Dueland, S.
    Kvalheim, G.
    CYTOTHERAPY, 2017, 19 (05) : S15 - S15
12345